United Kingdom Anti-Doping (UKAD) will investigate the circumstances surrounding the ‘adverse finding’ in the Conor Benn VADA test which derailed his clash with Chris Eubank Jr this week.
The report comes Riath Al-Samarrai of MailSport, who broke the story on Wednesday, and says UKAD plan on writing to VADA to request analysis of Benn’s test result. Al-Samarrai also says that VADA have indicated that no contractual barriers to a fighter prevent them from communicating with other regulatory doping bodies.
Trace amounts of the female fertility drug clomifene were detected in the A sample, with the results of the secondary B sample still yet to be tested. Clomifene has been shown to increase production of testosterone in males and also has the potential to be used as a masking agent to hide traces of other performance-enhancing substances.
Benn could face a ban of up to four years unless he is able to prove his innocence, although it is unlikely a different result will emerge from the B sample which almost always return the same result as that found in the A.
The twenty-six-year-old insisted he is a ‘clean fighter’ in the aftermath of the news during the week.